Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

22373-78-0

Monensin sodium salt

22373-78-0
1019-45-0

Methylbufotenin

1019-45-0
57-27-2

Morphine

57-27-2
552-79-4

Methylephedrine

552-79-4
443-48-1

Metronidazole

443-48-1
51596-11-3

Milbemycine

51596-11-3
148-82-3

Melphalan

148-82-3
50-44-2

Mercaptopurine

50-44-2
70476-82-3

Mitoxanthrone HCl

70476-82-3
72-33-3

Mestranol

72-33-3
1246820-20-1

Medetomidine-d3 Hydrochloride

1246820-20-1
61-68-7

Mefenamic acid

61-68-7
434-05-9

Methenolone Acétate

434-05-9
303-42-4

Methenolone Enanthate

303-42-4
16142-27-1

Molsidomine Impurity A

16142-27-1
62-51-1

Methacholine Chloride

62-51-1
851976-50-6

Monepantel

851976-50-6
851976-52-8

Monepantel Sulfone

851976-52-8
115550-35-1

Marbofloxacin

115550-35-1
56341-08-3

Mabuterol

56341-08-3